AHPA Legal Alert
Editor's Note: FDA would receive a total of $5.21 billion under a 2018 omnibus spending bill signed by President Trump today, $483.4 million more than in fiscal 2017. Of that amount, $2.9 billion will be federal discretionary appropriations and $2.4 billion will be generated through user fee revenue. FDA's discretionary budget will increase by $134 million above fiscal year 2017. The vast majority of that increase ($94 million) will fund increased FDA efforts to combat the opioid epidemic. Additional increases for FDA include $15 million for FDA to enhance its Oncology Center of Excellence, $10 million to address increased workload needs in the animal drug centers, and $10.5 million for FDA to work with states to implement the Food Safety Modernization Act (FSMA). FDA is also receiving an increase of $1 million to review botanical drug and dietary supplement interactions.

Regulatory Focus
March 23, 2018


President Donald Trump on Friday signed the $1.3 trillion spending bill to fund the government through 30 September.

The omnibus will bring the US Food and Drug Administration's (FDA) budget to a total of $2.9 billion in discretionary funding (meaning not user fees), $135 million above the 2017 enacted level, according to the  House Appropriations Committee.

According to the Alliance for a Stronger FDA, compared to the last FY 2018 continuing resolution, the omnibus will add $41 million in additional discretionary funding.

[ READ MORE... ]  

For more news from AHPA, follow us on social media: